For the Inventor, By the Inventor

Enter assignee name

Gruppo Lepetit

USPTO Granted Patents = 188

CIPO Patents = 1

Forward Citations = 953

Loading Chart...

Loading Chart...

127 inventors (with patents filed for the assignee):

Adriano Malabarba (27 out of 31 patents)

Bruno Cavalleri (25 out of 26 patents)

Romeo Ciabatti (23 out of 29 patents)

4. Enrico Selva (19 out of 27 patents)

5. Giorgio Tarzia (19 out of 19 patents)

6. Maurizio Denaro (16 out of 19 patents)

7. Giancarlo Lancini (14 out of 15 patents)

8. Pietro Consonni (14 out of 14 patents)

9. Francesco Parenti (12 out of 15 patents)

10. Aldo Trani (12 out of 12 patents)

11. Carolina Coronelli (12 out of 14 patents)

12. Gianbattista Panzone (11 out of 25 patents)

13. Paolo Strazzolini (11 out of 12 patents)

14. Giulio Galliani (11 out of 36 patents)

15. Angelo Borghi (11 out of 13 patents)

Core Competencies:

Glycopeptide Antibiotics

Antibiotic Purification

Teicoplanin Derivatives

N-acylaminoglucuronyl Aglycons

Antimicrobial Agents

Tetrapeptides

Antibiotic Recovery

Ester Derivatives

Pharmaceutical Formulations

Inhibitors

Immunosuppressive Agents

188 patents: Sort by Forward Citations

1. 6573366 - Process for the purification of human interleukin-1 receptor antagonist from recombinant E. coli (2003-06-03),

2. 6228851 - Process for the purification of 11&bgr;-21-dihydroxy-2′-methyl-5′&bgr;H-pregna-1,4-dieno[17,16-D]oxazole-3,20-dione (2001-05-08),

3. 6159746 - Solid phase immunoassay to detect inhibitors of proteolytic enzymes (2000-12-12),

4. 6133254 - Use of aspirochlorine or derivatives thereof as immunosuppressive agents (2000-10-17),

5. 6103895 - Preparation of (2000-08-15),

6. 6040297 - Dinucleoside-5',5'-pyrophosphates (2000-03-21),

7. 5990160 - Use of tropolone derivatives as inhibitors of the enzyme inositol (1999-11-23),

8. 5981716 - Process for the purification of proteins (1999-11-09),

9. 5939523 - Purification of dalbaheptide antibiotics by isoelectric focusing (1999-08-17),

10. 5882900 - Process for the selective increase of production of antibiotic GE 2270 (1999-03-16),

11. 5869449 - 38-decarboxy-38-hydroxymethyl derivatives of teiocoplanin antibiotics (1999-02-09),

12. 5854036 - Sesquiteterpenic dervatives (1998-12-29),

13. 5843890 - Antibiotic GE 2270 factors B.sub.1, B.sub.2, C.sub.1, C.sub.2, D.sub.1, (1998-12-01),

14. 5786350 - 36-derivatives of rifamycins and their use as antimicrobial agents (1998-07-28),

15. 5777125 - Process for the preparation of tertiary carbinols containing an amino (1998-07-07),

Company Overview

Gruppo Lepetit, based in Milan, specializes in the development and manufacturing of innovative antibiotic solutions, focusing on glycopeptide antibiotics and their derivatives. The company is recognized for its expertise in antibiotic purification and recovery processes, particularly in the production of teicoplanin derivatives and N-acylaminoglucuronyl aglycons. With a commitment to advancing antimicrobial agents and tetrapeptides, Gruppo Lepetit plays a significant role in addressing global health challenges related to antibiotic resistance.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

188 Patents

#15 in Milan

#43 in Italy

#4,477 in the World

Gruppo Lepetit

Forward Citations = 953

127 inventors:

Adriano Malabarba (27 out of 31 patents)

Bruno Cavalleri (25 out of 26 patents)

Romeo Ciabatti (23 out of 29 patents)

4. Enrico Selva (19 out of 27 patents)

5. Giorgio Tarzia (19 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gruppo Lepetit. Retrieved from https://idiyas.com/company/gruppo-lepetit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…